Research activity:
- Pharmacy (year: IV; semester: VIII) - monitored pharmacotherapy
- Laboratory Medicine (year III; semester: V) - pharmacology
- Cosmetology (year: II; semester: IV) - pharmacology
Laboratory techniques:
- Liquid chromatography (HPLC-UVIS, HPLC-ECD, HPLC-FLU).
- Immunoenzymatic techniques (ELISA).
- Electrophoretic techniques (Western immunoblot).
- Real-time PCR.
Publications:
Serum metabolic fingerprinting after exposure of rats to quinolinic acid. Kalaska B, Ciborowski M, Domaniewski T, Czyzewska U, Godzien J, Miltyk W, Kretowski A, Pawlak D. J Pharm Biomed Anal. 2016
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.Tankiewicz-Kwedlo A, Hermanowicz J, Surażynski A, Rożkiewicz D, Pryczynicz A, Domaniewski T, Pawlak K, Kemona A, Pawlak D. Mol Cell Biochem. 2016
The Biomechanical Testing for the Assessment of Bone Quality in an Experimental Model of Chronic Kidney Disease. Oksztulska-Kolanek E, Znorko B, Michałowska M, Pawlak K. Nephron. 2016
Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Pawlak K, Mysliwiec M, Pawlak D. Clin Biochem. 2015
oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients. Pawlak K, Mysliwiec M, Pawlak D. Thromb Res. 2014
Effect of diabetes and oxidative stress on plasma CCL23 levels in patients with severe chronic kidney disease. Pawlak K, Myśliwiec M, Pawlak D. Pol Arch Med Wewn. 2014
YKL-40 in hemodialyzed patients with and without cardiovascular complications - the enhancement by the coexistence of the seropositivity against hepatitis C virus infection. Pawlak K, Rozkiewicz D, Mysliwiec M, Pawlak D. Cytokine. 2013
Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients? Pawlak K, Mysliwiec M, Pawlak D. Life Sci. 2013
The alteration in Cu/Zn superoxide dismutase and adhesion molecules concentrations in diabetic patients with chronic kidney disease: the effect of dialysis treatment. Pawlak K, Mysliwiec M, Pawlak D. Diabetes Res Clin Pract. 2012
IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report. Kuklinski A, Kamocki Z, Koda M, Piotrowski Z, Sulkowski S, Lesniewicz R, Pawlak K, Mysliwiec P, Kedra B. Oncol Lett. 2011
Oxidized LDL to autoantibodies against oxLDL ratio - the new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients. Pawlak K, Mysliwiec M, Pawlak D. Atherosclerosis. 2012
Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? Pawlak K, Ulazka B, Mysliwiec M, Pawlak D. Transl Res. 2012